Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

MMP13-IN-2

🥰Excellent
Catalog No. T41079Cas No. 935759-55-0
Alias MMP13-IN-2

MMP13-IN-2 is a highly potent, selective, and orally active inhibitor of MMP-13. It demonstrates exceptional potency against MMP-13, with an IC50 value of 0.036 nM, and exhibits selectivities greater than 1,500-fold over MMP-1, 3, 7, 8, 9, 14, and TACE. Moreover, MMP13-IN-2 possesses the capability to effectively inhibit collagen release from cartilage in vitro. Consequently, MMP13-IN-2 holds great potential for advancing research on collagenase-related diseases.

MMP13-IN-2

MMP13-IN-2

🥰Excellent
Catalog No. T41079Alias MMP13-IN-2Cas No. 935759-55-0
MMP13-IN-2 is a highly potent, selective, and orally active inhibitor of MMP-13. It demonstrates exceptional potency against MMP-13, with an IC50 value of 0.036 nM, and exhibits selectivities greater than 1,500-fold over MMP-1, 3, 7, 8, 9, 14, and TACE. Moreover, MMP13-IN-2 possesses the capability to effectively inhibit collagen release from cartilage in vitro. Consequently, MMP13-IN-2 holds great potential for advancing research on collagenase-related diseases.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
MMP13-IN-2 is a highly potent, selective, and orally active inhibitor of MMP-13. It demonstrates exceptional potency against MMP-13, with an IC50 value of 0.036 nM, and exhibits selectivities greater than 1,500-fold over MMP-1, 3, 7, 8, 9, 14, and TACE. Moreover, MMP13-IN-2 possesses the capability to effectively inhibit collagen release from cartilage in vitro. Consequently, MMP13-IN-2 holds great potential for advancing research on collagenase-related diseases.
Targets&IC50
MMP2:180 nM (IC50), MMP13:0.036 nM (IC50), MMP3:1100 nM (IC50)
In vitro
In a study examining chondrocyte-mediated degradation of cartilage, bovine nasal cartilage (BNC) slices were cultured for up to 14 days. The compound MMP13-IN-2, at concentrations ranging from 0.01 to 1 μM, was found to effectively inhibit the IL-1/OSM-induced degradation of BNC in vitro, with inhibition percentages of -17.6%, 48.4%, and 70.8%, respectively.[1].
In vivo
MMP13-IN-2, administered via oral gavage at a dose of 1 mg/kg, demonstrates an optimal balance between the risk of CYP3A4 inhibition and oral bioavailability in both rats and mice, with bioavailability percentages (F%) of 33 and 38, respectively[1].
SynonymsMMP13-IN-2
Chemical Properties
Molecular Weight506.51
FormulaC24H19FN6O4S
Cas No.935759-55-0
SmilesFc1cccc(c1)-c1csc2[nH]c(nc(=O)c12)C(=O)NCc1cccc(OCCOc2ncn[nH]2)c1
Relative Density.1.53 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy MMP13-IN-2 | purchase MMP13-IN-2 | MMP13-IN-2 cost | order MMP13-IN-2 | MMP13-IN-2 chemical structure | MMP13-IN-2 in vivo | MMP13-IN-2 in vitro | MMP13-IN-2 formula | MMP13-IN-2 molecular weight